Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

類似資料

• LDL-C Goal Attainment With Ezetimibe Plus Simvastatin Coadministration vs Atorvastatin or Simvastatin Monotherapy in Patients at High Risk of CHD
  著者:: McKenney, James, 等
  出版事項: (2005)
• Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US
  著者:: Marrett, Elizabeth, 等
  出版事項: (2014)
• Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterolemia
  著者:: Goldberg, Ronald B., 等
  出版事項: (2010)
• Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years
  著者:: Constance, Christian, 等
  出版事項: (2014)
• Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended‐Release Niacin in Hyperlipidemic Patients
  著者:: Le, Ngoc‐Anh, 等
  出版事項: (2013)